Yuki serves as a Principal at Mitsui Global Investment, where he focuses on Healthcare AI investments.

He led investments into Stately Bio, Leash Bio, Ellipsis Health, Rhino FCP & supported investments into RallyBio, Bionova, Ensem Tx, Neura Health.

Previously an investment manager at Mitsui & Co., he gained experience in structuring corporate insurance programs, trading commodity derivatives, and managing private equity fund investments.

Yuki received his Bachelor of Economics degree from The University of Tokyo. He is a  Certified Member Analyst of the Securities Analysts Association of Japan, and holds the Chartered Financial Analyst® designation.

In his free time, he likes to workout or to lose count of time playing boardgames such as Brass, Terraforming Mars or Poker.